Association across weeks to treatment for three genera. by Katrine Carlsen (5477300)

Subjects:

Genera associated with FC, symptom score or week to treatment. by Katrine Carlsen (5477300)

Subjects:

Changes in alpha diversity in the weeks before anti-TNF-a treatment. by Katrine Carlsen (5477300)

Subjects:

Family clades associating with week to treatment, symptom score or FC. by Katrine Carlsen (5477300)

Subjects:

Alpha diversity measures across all 727 samples. by Katrine Carlsen (5477300)

Subjects:

Summary statistics for analysis of single genera clades. by Katrine Carlsen (5477300)

Subjects:

Abundance of the top 20 most abundant genera in one patient (Patient 1), across the weeks running up to treatment. by Katrine Carlsen (5477300)

Subjects:

Development of alpha diversity across weeks towards a new TNF treatment for each IBD disease subtype. by Katrine Carlsen (5477300)

Subjects:

Community composition of samples from five individuals show clustering of samples according to individual. by Katrine Carlsen (5477300)

Subjects:

Study taxonomy. by Katrine Carlsen (5477300)

Subjects:

Microbiome profile of the most abundant phyla in one patient (Patient 1), across 12 infliximab treatments (-1 is the week before treatment, -2 the two weeks before treatment, etc). by Katrine Carlsen (5477300)

Subjects:

S5 Fig - by Katrine Carlsen (5477300)

Subjects:

Summary statistics for analysis of single family clades. by Katrine Carlsen (5477300)

Subjects:

STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Subjects:

Shuffling identity decreases behavior trajectory uniqueness. by Catalin Mitelut (5587493)

S1 File - by Jacob P. Rastas (20642173)

Subjects:

Path analysis diagram illustrating the associations between alexithymia, social support, anticipated stigma and patient satisfaction, with their respective correlation coefficients... by Keya Bibikar (22386306)

Analysis of Significantly Different ARGs and Resistance Mechanisms. by Xu Jia (187142)

Analysis of the Nugent score before (T=0) and after (T=1) the use of the vaginal gel. Number of participants and respective percentages of Nugent scores before and after the intervention. A statistically significant decrease in Nugent scores was observed after the intervention (p value =0.0047). by Adriana Bittencourt Campaner (21175462)

“…Number of participants and respective percentages of Nugent scores before and after the intervention. A statistically significant decrease in Nugent scores was observed after the intervention (p value =0.0047).…”

Data Sheet 1_Validation of an MPS-based intestinal cell culture model for the evaluation of drug-induced toxicity.docx by Stefanie Hoffmann (3756733)

“…Overall, from the 23 tested compounds, 15 showed the expected outcome, i.e., the compound led to a decrease of the TEER for the positive control compounds, or the TEER value remained stable after treatment with non-GI-toxic compounds.…”